IP Library › Assignment 041765/0767
Patent Assignment
Reel/Frame 041765/0767

Assignment of Assignor's Interest

Recorded: 2017-03-28 Pages: 4
Assignors
KLASSEN, PRESTON
Executed: 2015-01-27
TAYLOR, KRISTIN
Executed: 2015-02-12
Assignee
OREXIGEN THERAPEUTICS, INC.
3344 NORTH TORREY PINES COURT, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Property (1)
Compositions and Methods for Reducing Major Adverse Cardiovascular Events
Application: 15/101,878 →
Publication: US 2016/0310485
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest Sep 20, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 047115/0102 →
Security Interest May 6, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 049092/0156 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050520/0149 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →